US EditionTrump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies
Nine pharmaceutical firms agreed to lower U.S. drug prices to align with other developed nations under the Trump administration’s Most Favored Nation policy, promising billions in savings.
- On Friday, President Donald Trump announced agreements with nine pharmaceutical groups to lower United States drug prices under the most-favoured-nation pricing policy in exchange for tariff relief.
- In July the administration pressed most-favoured-nation pricing to align U.S. drug costs with price-controlled countries and pressured several previously negotiating firms including Pfizer, AstraZeneca, Eli Lilly, Novo Nordisk, EMD Serono.
- Selected medicines, including Amgen's Repatha and Sanofi's Plavix, will be offered at discounts up to 70% through the TrumpRx channel, set to launch early next year.
- The White House said the agreements with nine firms will yield `billions of dollars in savings`, while Democrats and lawmakers raised concerns about opaque negotiations and sought information.
- Analysts told clients that three companies remain outside the deals and are expected to fall in line soon, with negligible effects on industry sales and profits, according to statements last week.
16 Articles
16 Articles
Most people have insurance through work, the individual insurance market, or government programs like Medicaid and Medicare, which protect them from much of the cost.
MedPage Today
Anti-Aging, Acupuncture and Health NewsTrump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies
(MedPage Today) -- President Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences...
We're reading about new TrumpRx deals, Samsung Biologics' first U.S. plant, and more
Good morning, Jason Mast here filing in for Ed on this Christmas week. No coffee this morning — well, not yet — but rather some Yemeni Tea from a certain rapidly expanding New York haunt. It’s sweeter than my usual cup and warmer. Ten out of ten. Anyway, here’s some news for you today. I know it’s not much, by way of a gift, but it’s all we have…. The White House unveiled its largest batch of drug pricing agreements, announcing deals with Amgen…
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
